Status:
RECRUITING
Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.
Lead Sponsor:
Santen SAS
Conditions:
Myopia
Eligibility:
All Genders
5+ years
Brief Summary
This study aims to assess the impact of myopia in childhood and its long-term complications in adulthood on health-related Quality of Life (HRQoL), providing valuable data for cost-effectiveness model...
Eligibility Criteria
Inclusion
- Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their spherical equivalent (SER): Low myopia is from -0.5 D (inclusive) to -3.0 D (inclusive), Moderate myopia is from -3.0 D to -6.0 D (inclusive) and High myopia is \<-6.0 D.
- Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.
- Patients where myopia is a known or likely contributing factor to the complication.
Exclusion
- Parents (or other proxy) of children aged 4 years and below.
- Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded
Key Trial Info
Start Date :
July 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06912802
Start Date
July 29 2025
End Date
December 1 2025
Last Update
August 7 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital
Copenhagen, Denmark
2
University Hospital Necker Enfants Malades
Paris, France
3
Klinik für Augenheilkunde (Universitätsklinikum Freiburg)
Freiburg im Breisgau, Germany
4
Universitäts-Augenklinik Mainz
Mainz, Germany